UTHR vs. CTLT

Last updated Jun 6, 2026

UTHR (United Therapeutics Corporation) and CTLT (Catalent, Inc.) are both stocks. Both are in the Healthcare sector — UTHR in Biotechnology, CTLT in Drug Manufacturers - Specialty & Generic. At a 0.29 correlation, their price movements are largely independent.

Performance

UTHR vs. CTLT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Catalent, Inc. (CTLT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

UTHR

• 1D: 0.40%
• 1M: -7.86%
• YTD: 12.85%
• 6M: 12.38%
• 1Y: 71.99%
• 3Y*: 35.66%
• 5Y*: 25.60%
• 10Y*: 16.80%

CTLT

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

UTHR vs. CTLT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
UTHR United Therapeutics Corporation	12.85%	38.09%	60.46%	-20.93%	28.70%	42.35%	72.33%	-19.12%	-26.39%	3.15%
CTLT Catalent, Inc.	0.00%	0.00%	41.29%	-0.18%	-64.84%	23.02%	84.85%	80.56%	-24.10%	52.37%

Correlation

The correlation between UTHR and CTLT is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.10
Correlation (5Y) Calculated over the trailing 5-year period	0.13
Correlation (10Y) Calculated over the trailing 10-year period	0.26
Correlation (All Time) Calculated using the full available price history since Aug 1, 2014	0.29

The correlation between UTHR and CTLT shifts across timeframes, from 0.10 (3 years) to 0.29 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM) UTHR : $3.17B CTLT : $4.42B
Gross Profit (TTM) UTHR : $2.74B CTLT : $965.00M
EBITDA (TTM) UTHR : $1.75B CTLT : $399.00M

Return for Risk

UTHR vs. CTLT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR

UTHR Risk / Return Rank: 87
UTHR Sharpe Ratio Rank: 81
UTHR Sortino Ratio Rank: 87
UTHR Omega Ratio Rank: 88
UTHR Calmar Ratio Rank: 90
UTHR Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. CTLT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Catalent, Inc. (CTLT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	UTHR	CTLT	Difference
Sharpe ratio: Return per unit of total volatility	1.45	—	—
Sortino ratio: Return per unit of downside risk	2.89	—	—
Omega ratio: Gain probability vs. loss probability	1.39	—	—
Calmar ratio: Return relative to maximum drawdown	4.43	—	—
Martin ratio: Return relative to average drawdown	11.34	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	UTHR	CTLT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.45	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.73	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.38	—	—

Drawdowns

Drawdown Indicators

	UTHR	CTLT	Difference
Max Drawdown Largest peak-to-trough decline	-93.18%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-16.35%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-33.00%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-33.00%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-55.56%	—	—
Current Drawdown Current decline from peak	-7.86%	—	—
Average Drawdown Average peak-to-trough decline	-35.31%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	6.37%	—	—

Volatility

Volatility by Period

	UTHR	CTLT	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.84%	—	—
Volatility (6M) Calculated over the trailing 6-month period	26.00%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	49.78%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.14%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	35.08%	—	—

Dividends

UTHR vs. CTLT - Dividend Comparison

Neither UTHR nor CTLT has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both UTHR and CTLT in my portfolio?

UTHR and CTLT have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.